IRME — IR-MED Cashflow Statement
0.000.00%
Last trade - 00:00
- $42.41m
- $42.17m
- 12
- 38
- 27
- 15
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.248 | -0.752 | -3.72 | -4.73 | -4.91 |
Depreciation | |||||
Non-Cash Items | 0.02 | 0.025 | 1.35 | 1.3 | 1.68 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.154 | 0.324 | -0.121 | 0.047 | -0.019 |
Change in Accounts Receivable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -0.072 | -0.402 | -2.48 | -3.38 | -3.23 |
Capital Expenditures | — | — | -0.031 | -0.05 | -0.002 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | -0.03 | -0.009 | 0 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | — | -0.061 | -0.059 | -0.002 |
Financing Cash Flow Items | 0 | 1.96 | 3.49 | 3.63 | 1 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 0.3 | 2.04 | 3.49 | 3.63 | 1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.223 | 1.63 | 0.949 | 0.187 | -2.23 |